Ambry

The American College of Medical Genetics and Genomics last week issued a clarification to recommendations it released in March about how providers of clinical exome and whole-genome sequencing tests should deal with incidental findings.

NEW YORK (GenomeWeb News) – RainDance Technologies said today that it has launched a new service program to support its customers who are developing sequencing-based genetic testing panels.

Ambry Genetics and GE Healthcare, who each released a new 26-gene sequencing service last week, have disclosed that both of their new services are based on Illumina's TruSight Tumor panel for somatic variant detection in solid tumors on the MiSeq platform.

Illumina has launched TruSight Tumor Content, an amplicon-based panel that targets 26 oncogenes and tumor suppressor genes selected associated with common solid tumors, including lung, colon, melanoma, gastric, and ovarian cancer.

PHOENIX (GenomeWeb News) – Whole-exome sequencing is inching its way into the clinic, and at the American College of Medical Genetics and Genomics annual meeting held here geneticists and clinicians showed how such sequencing could be used to find diagnoses for patients whose conditions had remai

With 10,000 next-generation sequencing-based diagnostic tests performed since 2010, including more than 1,000 exome sequencing tests, Ambry Genetics plans to develop additional panels in the areas of rare disease and oncology, and expand some of its existing panels.

NEW YORK (GenomeWeb News) – Exact Sciences said in its 10-K filing with the US Securities and Exchange Commission this week that in December it entered into an amendment to a licensing agreement pursuant to which Hologic granted the company a non-exclusive worldwide license to certain Hologic pat

Agilent Technologies and PerkinElmer have signed an agreement that will see PerkinElmer's Signature Genomics business switch to Agilent arrays for its genetic testing services.

This story has been updated to include comments from a Roche NimbleGen service provider and a Roche spokesperson.

Early adopters of clinical sequencing are all taking slightly different approaches — from whole-genome sequencing to exome sequencing to targeted panels — but one of the key hurdles they all face is interpretation and analysis, according to speakers at Cambridge Healthtech Instit

Pages

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.